Tag: CRISPR
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
CRISPR Gene Therapy Shows Promise for Children with Sickle Cell Disease and Beta-Thalassemia
CRISPR gene therapy exa-cel achieved 95% efficacy in eliminating blood transfusions for children with beta-thalassemia and sickle cell disease. New…
Small-Molecule Drugs Enable Safer, More Precise Therapeutic Genome Editing
New research shows small-molecule drugs can precisely control therapeutic genome editing, achieving 85% improved accuracy while reducing off-target effects by…
Submit Your Paper to GMJ
No APC until January 2027.

